FAKTOR OPTIONSSCHEIN - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 15:25:49 19/06/2024 BST | ||
| 6.64 EUR | 0.00% |
|
| Current month | -3.63% | ||
| 1 month | -7.39% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 19/06/24 | 6.64 | 0.00% |
| 18/06/24 | 6.64 | 0.00% |
| 17/06/24 | 6.64 | -1.78% |
| 14/06/24 | 6.76 | +0.45% |
| 13/06/24 | 6.73 | -0.15% |
Real-time BOERSE MUENCHEN
Last update June 19, 2024 at 03:25 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GX4LU5 |
| ISIN | DE000GX4LU50 |
| Date issued | 02/12/2021 |
| Strike | 68.51 $ |
| Maturity | Unlimited |
| Parity | 9.78 : 1 |
| Emission price | 9.87 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.05 € |
|---|---|
| Lowest since issue | 5.5 € |
| Spread | 0.05 € |
| Spread % | 0.75% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
137.3
USD
Average target price
147
USD
Spread / Average Target
+7.06%
- Stock Market
- Certificates
- Certificat
